Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Laboratory competitive bidding

This article was originally published in The Gray Sheet

Executive Summary

American Clinical Laboratory Association accuses CMS in a June 20 letter of putting "the cart before the horse" in asking for comments on a proposed bidding form. Although a three-year demonstration project for competitive bidding for lab services, as mandated under the Medicare Modernization Act, was originally expected to begin in early 2007, plans to implement the demo have yet to emerge (1"The Gray Sheet" Dec. 5, 2005, p. 13). ACLA notes that "the form itself suggests that CMS has significantly underestimated the complexity of [the program] and the unique and serious issues that will be presented." Similarly, AdvaMed states in June 19 comments that CMS has underestimated the burden of completing the form and urges the agency to take patient satisfaction and ease of access into account in monitoring the demo...

You may also be interested in...



Lab Competitive Bidding Project Will Need To Address New Tests – Attorney

CMS needs to decide how new technology codes will be incorporated into a competitive bidding lab demonstration program, according to Alston & Bird attorney Peter Kazon

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel